Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AddaMAP: Daptomycin for Pneumococcal Meningitis
NCT03480191Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Jun 2018
- Primary completion
- May 2024
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of daptomycin in pneumococcal meningitis, sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Started Jun 2018; status: completed.
02
Drugs
daptomycin
03
Conditions
pneumococcal meningitis
Beyond the preview
Go deeper on NCT03480191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03480191.